Literature DB >> 34116029

A Pilot Study on Automatic Three-Dimensional Quantification of Barrett's Esophagus for Risk Stratification and Therapy Monitoring.

Sharib Ali1, Adam Bailey2, Stephen Ash3, Maryam Haghighat4, Simon J Leedham5, Xin Lu6, James E East2, Jens Rittscher7, Barbara Braden8.   

Abstract

BACKGROUND & AIMS: Barrett's epithelium measurement using widely accepted Prague C&M classification is highly operator dependent. We propose a novel methodology for measuring this risk score automatically. The method also enables quantification of the area of Barrett's epithelium (BEA) and islands, which was not possible before. Furthermore, it allows 3-dimensional (3D) reconstruction of the esophageal surface, enabling interactive 3D visualization. We aimed to assess the accuracy of the proposed artificial intelligence system on both phantom and endoscopic patient data.
METHODS: Using advanced deep learning, a depth estimator network is used to predict endoscope camera distance from the gastric folds. By segmenting BEA and gastroesophageal junction and projecting them to the estimated mm distances, we measure C&M scores including the BEA. The derived endoscopy artificial intelligence system was tested on a purpose-built 3D printed esophagus phantom with varying BEAs and on 194 high-definition videos from 131 patients with C&M values scored by expert endoscopists.
RESULTS: Endoscopic phantom video data demonstrated a 97.2% accuracy with a marginal ± 0.9 mm average deviation for C&M and island measurements, while for BEA we achieved 98.4% accuracy with only ±0.4 cm2 average deviation compared with ground-truth. On patient data, the C&M measurements provided by our system concurred with expert scores with marginal overall relative error (mean difference) of 8% (3.6 mm) and 7% (2.8 mm) for C and M scores, respectively.
CONCLUSIONS: The proposed methodology automatically extracts Prague C&M scores with high accuracy. Quantification and 3D reconstruction of the entire Barrett's area provides new opportunities for risk stratification and assessment of therapy response.
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Deep learning; Esophageal cancer; Imaging; Risk assessment; Three-dimensional

Mesh:

Year:  2021        PMID: 34116029     DOI: 10.1053/j.gastro.2021.05.059

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  4 in total

Review 1.  Artificial Intelligence in the Management of Barrett's Esophagus and Early Esophageal Adenocarcinoma.

Authors:  Franz Ludwig Dumoulin; Fabian Dario Rodriguez-Monaco; Alanna Ebigbo; Ingo Steinbrück
Journal:  Cancers (Basel)       Date:  2022-04-10       Impact factor: 6.575

2.  Identification of Barrett's esophagus in endoscopic images using deep learning.

Authors:  Wen Pan; Xujia Li; Weijia Wang; Linjing Zhou; Jiali Wu; Tao Ren; Chao Liu; Muhan Lv; Song Su; Yong Tang
Journal:  BMC Gastroenterol       Date:  2021-12-17       Impact factor: 3.067

Review 3.  Machine Learning for Future Subtyping of the Tumor Microenvironment of Gastro-Esophageal Adenocarcinomas.

Authors:  Sebastian Klein; Dan G Duda
Journal:  Cancers (Basel)       Date:  2021-09-30       Impact factor: 6.575

Review 4.  Anatomical Engineering and 3D Printing for Surgery and Medical Devices: International Review and Future Exponential Innovations.

Authors:  José Cornejo; Jorge A Cornejo-Aguilar; Mariela Vargas; Carlos G Helguero; Rafhael Milanezi de Andrade; Sebastian Torres-Montoya; Javier Asensio-Salazar; Alvaro Rivero Calle; Jaime Martínez Santos; Aaron Damon; Alfredo Quiñones-Hinojosa; Miguel D Quintero-Consuegra; Juan Pablo Umaña; Sebastian Gallo-Bernal; Manolo Briceño; Paolo Tripodi; Raul Sebastian; Paul Perales-Villarroel; Gabriel De la Cruz-Ku; Travis Mckenzie; Victor Sebastian Arruarana; Jiakai Ji; Laura Zuluaga; Daniela A Haehn; Albit Paoli; Jordan C Villa; Roxana Martinez; Cristians Gonzalez; Rafael J Grossmann; Gabriel Escalona; Ilaria Cinelli; Thais Russomano
Journal:  Biomed Res Int       Date:  2022-03-24       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.